India bans wellness wonder ashwagandha's leaf products on health risk
Published on: April 18, 2026, 6 a.m. | Source: Livemint
The move could disrupt formulations in India’s $38.77 billion nutraceuticals industry, where ashwagandha is a key product with its market estimated at $928.5 million in 2026.
